The hereditary spastic paraplegias are a group of neurological conditions which are characterised by the presence of progressive spasticity, predominantly affecting the legs. They may be subclassified into pure and complicated forms based on the presence of additional neurological or non-neurological features.
The principal clinical feature of pHSP is, by definition, the presence of a progressive spastic paraplegia. Often this is of insidious onset and the abnormal gait is frequently noticed by relatives before the affected person becomes aware of it. 8 9 Age at onset may range from early childhood, with delayed motor milestones and "clumsiness", to adult life.5 8 9 Age at onset is not consistent between families, although it is consistent within some families.5 8 9 There is also considerable variation in disease severity. Affected subjects may range from entirely asymptomatic (10-20% of cases) to chairbound (10-1 5% of cases).5 8 9 Although severity tends to increase with disease duration, considerable variation is present even when people who have been affected for the same length of time are compared.5 8 Urinary symptoms are common, and 50% of patients may be affected by urinary frequency, urgency, or hesitancy.5 8 Subjects from type II families had a disorder which progressed more rapidly and was more commonly associated with somatosensory and urinary sphincter disturbances than subjects from type I families. Muscular weakness predominated in type II families, while hypertonicity was more marked in type I families. However, there was considerable overlap between these two groups and subsequent studies have not consistently supported the concept of two distinct types of pHSP. 8 9 No consistent clinical differences are apparent between families with different inheritance patterns.
PATHOLOGY
Pathological reports for pHSP are scant and have usually described patients with long 499 standing disease. The principal pathological finding is of axonal degeneration involving the terminal ends of the longest fibres of the corticospinal tracts and dorsal columns. The spinocerebellar tracts are involved to a lesser degree. The cell bodies of the degenerating fibres are apparently normal; the process has been described as "dying back" of the nerve fibre endings. There is no evidence of primary demyelination and no abnormality of peripheral nerves, dorsal roots, or dorsal root ganglia has been reported. ' Reid 
